Abstract:SND affects up to one in five patients with AF. The pathophysiological derangements in gene expression, ion channel metabolism, and alterations in myocardial architecture associated with AF may lead to anatomic and electrical changes in the region of the sinoatrial node. Ablation may improve symptoms associated with SND in patients with AF. Future randomized trials are needed to clarify the epidemiology and optimal management of patients with SND and AF.
“…23 In support to these notions, it seems that pulmonary vein isolation, apart from reducing AF burden and tachy-brady episodes, ameliorates sinus pauses and related symptoms as well. 23 In the present study, which included a greater number of patients than our previous pilot investigation, 15 we showed an independent association of RDW with AF in patients with SND. In addition, we demonstrated, for the first time, a significant association between γGT and AF in these patients, independently from RDW.…”
Section: Discussionmentioning
confidence: 93%
“…Indeed, up to 70% of patients implanted a dual chamber for SND may suffer AF, while in 40%–70% of SND patients atrial arrhythmias are evident at the time of diagnosis 3,4 . On the other hand, SND affects up to one in five patients with AF and it has been suggested that the structural and electrophysiological abnormalities associated with AF may provoke or aggravate sinus node dysfunction 23 . In support to these notions, it seems that pulmonary vein isolation, apart from reducing AF burden and tachy‐brady episodes, ameliorates sinus pauses and related symptoms as well 23 .…”
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
“…23 In support to these notions, it seems that pulmonary vein isolation, apart from reducing AF burden and tachy-brady episodes, ameliorates sinus pauses and related symptoms as well. 23 In the present study, which included a greater number of patients than our previous pilot investigation, 15 we showed an independent association of RDW with AF in patients with SND. In addition, we demonstrated, for the first time, a significant association between γGT and AF in these patients, independently from RDW.…”
Section: Discussionmentioning
confidence: 93%
“…Indeed, up to 70% of patients implanted a dual chamber for SND may suffer AF, while in 40%–70% of SND patients atrial arrhythmias are evident at the time of diagnosis 3,4 . On the other hand, SND affects up to one in five patients with AF and it has been suggested that the structural and electrophysiological abnormalities associated with AF may provoke or aggravate sinus node dysfunction 23 . In support to these notions, it seems that pulmonary vein isolation, apart from reducing AF burden and tachy‐brady episodes, ameliorates sinus pauses and related symptoms as well 23 .…”
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
“…Therefore, the present study does not overlap with the initial and still preliminary experiences evaluating left atrial AF ablation as a way to eliminate prolonged sinus pauses at the termination of AF episodes, with an approach that combines AF ablation and cessation of antiarrhythmic drugs 7 . Overall, the role of left atrial ablation to treat patients with sinus pauses suggestive of sinus node disease associated with AF is still not defined and in the relatively small non‐randomised studies available in literature, some patients still required permanent cardiac pacing during follow‐up 8 …”
“…However, it is not clear whether it is the restoration of normal sinus rhythm or the cessation of antiarrhythmic or rate-controlling drugs that provides benefit. The population that would most benefit from ablation has not yet been fully characterized [26].…”
Section: Clinical Implications and Potential Treatmentsmentioning
Purpose-This study aimed to determine the incidence, prevalence, and predictors of atrial arrhythmias (AAs) in patients with symptomatic sinus node dysfunction (SND) who required permanent pacemaker implantation. Also, we evaluated the impact of atrial pacing (AP) on AAs. Methods-All consecutive patients who underwent pacemaker implantation from 2005 to 2011 were included. Atrial fibrillation (AF), atrial flutter (AFL), atrial tachycardia (AT), and AV nodal reentrant tachycardia (AVNRT) were detected via pacemaker interrogation and clinical documentation. Results-The study group included 322 patients (44% male) with mean age 68.8 ± 15 years and followed for an average of 5.6 ± 2.2 years (median 5.7 years). Overall, 61.8% were found to have any AA at follow-up. Individual prevalence of AAs was high as follows: AF 43.5%, AFL 6.5%, AT 25%, and AVNRT 6.8%. AF was documented in 23% of patients (n = 74) prior to pacemaker; among those, 15% (n = 11) had no recurrence of AF with average AP of 74%. The incidence of new-onset AF after pacemaker was 15.8%. In subgroup analysis, prevalence of AF was increased by 16% with high rate of AP (81-100%) and 17% with lower rate of AP (0-20%). Incidence of new-onset AF was not affected by AP. Diabetes, hypertension, and left atrial enlargement were predictors of AAs. White men and women had higher prevalence of AF. Conclusions-AAs are highly prevalent in SND, particularly in white patients. Paroxysmal AF is suppressed with AP in minority, but there is no impact of AP on new-onset AF. Patients with diabetes, hypertension, and dilated atria must be monitored closely for early detection of AAs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.